Insulet | PODD - Stock

Stock Price
243.86
Daily Change
-7.38 -2.94%
Monthly
-17.15%
Yearly
-15.23%
Q1 Forecast
247.93

Insulet reported $446.3M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Abbott USD 6.71B 246M Sep/2025
Align Technology USD 228.16M 15.59M Sep/2025
AtriCure USD 78.95M 2.61M Sep/2025
Avanos Medical USD 150.6M 7.9M Sep/2025
Baxter International USD 2.46B 76M Sep/2025
Becton, Dickinson and Co. USD 3.89B 55M Sep/2025
Boston Scientific USD 2.92B 60M Sep/2025
Cardinal Health USD 20.12B 2.56B Dec/2025
Cooper Companies USD 881M 252.3M Jun/2025
Dexcom USD 604.1M 33.4M Sep/2025
Edwards Lifesciences USD 1.14B 800K Sep/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Globus Medical USD 771.54M 592K Sep/2025
ICU Medical USD 622.44M 5.97M Sep/2025
Insulet USD 446.3M 600K Sep/2025
Integra LifeSciences USD 489.11M 23.98M Sep/2025
J&J USD 14.15B 734M Sep/2025
Masimo USD 338.6M 20.1M Sep/2025
Medtronic USD 6.16B 270M Sep/2025
Merit Medical Systems USD 326.55M 3.24M Sep/2025
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.05B 87M Sep/2025
Stryker USD 5.37B 81M Sep/2025
Tandem Diabetes Care USD 137.28M 5.29M Sep/2025
Teleflex USD 802.46M 108.78M Sep/2025
West Pharmaceutical Services USD 438M 16.9M Sep/2025
Zimmer Biomet Holdings USD 2.48B 29.5M Sep/2025